EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias.

PubWeight™: 2.43‹?› | Rank: Top 2%

🔗 View Article (PMID 16987158)

Published in Eur J Neurol on October 01, 2006

Authors

A May1, M Leone, J Afra, M Linde, P S Sándor, S Evers, P J Goadsby, EFNS Task Force

Author Affiliations

1: Department of Systems Neuroscience, University of Hamburg, Hamburg, Germany. a.may@uke.uni-hamburg.de

Associated clinical trials:

Verapamil as Therapy for Children and Young Adults With Dravet Syndrome | NCT01607073

Articles citing this

Cluster headache: clinical features and therapeutic options. Dtsch Arztebl Int (2011) 1.69

Clinical features of unilateral headaches beyond migraine and cluster headache and their response to indomethacin. Wien Klin Wochenschr (2011) 1.47

Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain (2013) 1.39

Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation. J Headache Pain (2014) 1.31

Understanding and managing dental and orofacial pain in general practice. Br J Gen Pract (2016) 1.30

Diagnostic and therapeutic errors in trigeminal autonomic cephalalgias and hemicrania continua: a systematic review. J Headache Pain (2013) 1.16

Diagnostic and therapeutic errors in cluster headache: a hospital-based study. J Headache Pain (2014) 1.14

Italian guidelines for primary headaches: 2012 revised version. J Headache Pain (2012) 1.10

Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012. J Headache Pain (2012) 1.02

Trigeminal autonomic cephalalgias: frequency in a general neurology clinic setting. J Headache Pain (2008) 0.98

Cluster headache. Orphanet J Rare Dis (2008) 0.96

A proposed roadmap for inpatient neurology quality indicators. Neurohospitalist (2011) 0.89

Cost-effectiveness of stimulation of the sphenopalatine ganglion (SPG) for the treatment of chronic cluster headache: a model-based analysis based on the Pathway CH-1 study. J Headache Pain (2015) 0.87

Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headache. Cephalalgia (2016) 0.86

Evidence-based treatments for cluster headache. Ther Clin Risk Manag (2015) 0.85

Meningioma causing gabapentin-responsive secondary SUNCT syndrome. J Headache Pain (2010) 0.85

Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic cluster headache. Cephalalgia (2015) 0.85

Cost-effectiveness analysis of non-invasive vagus nerve stimulation for the treatment of chronic cluster headache. J Headache Pain (2016) 0.83

Headache: Cluster headache treatment - RCTs versus real-world evidence. Nat Rev Neurol (2016) 0.82

Cluster headache with ptosis responsive to intranasal lidocaine application: a case report. J Med Case Rep (2012) 0.81

The Neuropharmacology of Cluster Headache and other Trigeminal Autonomic Cephalalgias. Curr Neuropharmacol (2015) 0.81

Efficacy of oxygen inhalation in sumatriptan refractory "high altitude" cluster headache attacks. J Headache Pain (2009) 0.81

Cardiac safety in cluster headache patients using the very high dose of verapamil (≥720 mg/day). J Headache Pain (2011) 0.80

[Facial and eye pain - Neurological differential diagnosis]. Ophthalmologe (2011) 0.79

Study protocol of Prednisone in episodic Cluster Headache (PredCH): a randomized, double-blind, placebo-controlled parallel group trial to evaluate the efficacy and safety of oral prednisone as an add-on therapy in the prophylactic treatment of episodic cluster headache with verapamil. BMC Neurol (2013) 0.79

Sphenopalatine (pterygopalatine) ganglion stimulation and cluster headache: new hope for ye who enter here. Cephalalgia (2013) 0.79

Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study. Headache (2016) 0.78

Trigeminal autonomic cephalalgias: A review of recent diagnostic, therapeutic and pathophysiological developments. Ann Indian Acad Neurol (2012) 0.78

Cluster headache and oxygen: is it possible to predict which patients will be relieved? A retrospective cross-sectional correlation study. J Neurol (2010) 0.77

Trigeminal autonomic cephalalgias: beyond the conventional treatments. Curr Pain Headache Rep (2014) 0.76

Treatment of cluster headache in pregnancy and lactation. Curr Pain Headache Rep (2010) 0.76

Ventral tegmental area deep brain stimulation for refractory chronic cluster headache. Neurology (2016) 0.76

Bilateral SUNCT-like headache in a patient with prolactinoma responsive to lamotrigine. J Headache Pain (2009) 0.76

Cluster headache. BMJ Clin Evid (2010) 0.75

Deep brain stimulation in trigeminal autonomic cephalalgias. Neurotherapeutics (2010) 0.75

High-Dose Verapamil in Episodic and Chronic Cluster Headaches and Cardiac Adverse Events: Is It as Safe as We Think? Drug Saf Case Rep (2015) 0.75

Sunct syndrome. Report of a case and treatment update. J Clin Exp Dent (2015) 0.75

Masquerades of cluster headache. Malays Fam Physician (2009) 0.75

The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1. Pharmacol Res Perspect (2015) 0.75

Guideline for primary care management of headache in adults. Can Fam Physician (2015) 0.75

[Guideline for primary care management of headache in adults]. Can Fam Physician (2015) 0.75

Bi-allelic and tri-allelic 5-HTTLPR polymorphisms and triptan non-response in cluster headache. J Headache Pain (2014) 0.75

High-flow oxygen therapy in cluster headache patients has no significant effect on nociception specific blink reflex parameters: a pilot study. J Headache Pain (2016) 0.75

Patient satisfaction with conventional, complementary, and alternative treatment for cluster headache in a Norwegian cohort. Scand J Prim Health Care (2014) 0.75

Cluster headache in Greece: an observational clinical and demographic study of 302 patients. J Headache Pain (2016) 0.75

Assessing and treating primary headaches and cranio-facial pain in patients undergoing rehabilitation for neurological diseases. J Headache Pain (2017) 0.75

Cluster headache and oxygen: is it possible to predict which patients will be relieved? A prospective cross-sectional correlation study. J Neurol (2013) 0.75

Acupuncture in cluster headache: four cases and review of the literature. Neurol Sci (2014) 0.75

Articles by these authors

Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol (1995) 12.98

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (2001) 6.61

New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97

Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 3.32

Hypothalamic activation in cluster headache attacks. Lancet (1998) 3.32

The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86

EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol (2006) 2.86

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia (2002) 2.78

A triptan too far? J Neurol Neurosurg Psychiatry (1998) 2.71

Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med (1999) 2.67

EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. Eur J Neurol (2010) 2.53

The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci. J Infect Dis (1993) 2.49

Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis. Genome Res (2001) 2.40

EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol (2009) 2.39

Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology (2002) 2.34

Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia (2010) 2.18

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia (2007) 2.11

Negative effects of famotidine on cardiac performance assessed by noninvasive hemodynamic measurements. Gastroenterology (1989) 2.07

Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol (2006) 2.04

Effect of norepinephrine on the outcome of septic shock. Crit Care Med (2000) 1.95

The prevalence of diabetes in Indians and Caucasians living in southwestern Ontario. Can J Public Health (1987) 1.93

Premonitory symptoms in migraine: an electronic diary study. Neurology (2003) 1.81

Peptide deformylase as an antibacterial drug target: target validation and resistance development. Antimicrob Agents Chemother (2001) 1.80

Brainstem activation specific to migraine headache. Lancet (2001) 1.80

The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab (1999) 1.77

Migraine, aura, and cortical spreading depression: why are we still talking about it? Ann Neurol (2001) 1.74

Greater occipital nerve injection in primary headache syndromes--prolonged effects from a single injection. Pain (2006) 1.72

Comorbidity of migraine and restless legs syndrome--a case-control study. Cephalalgia (2007) 1.71

Protein dynamics. Vibrational coupling, spectral broadening mechanisms, and anharmonicity effects in carbonmonoxy heme proteins studied by the temperature dependence of the Soret band lineshape. Biophys J (1992) 1.70

Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia (2009) 1.68

Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth (2008) 1.65

Migraine: preventive treatment. Cephalalgia (2002) 1.63

Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat. Cephalalgia (1992) 1.62

Friedreich ataxia in Italian families: genetic homogeneity and linkage disequilibrium with the marker loci D9S5 and D9S15. Am J Hum Genet (1990) 1.61

A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain (2005) 1.59

[Nasogastric tube: intratracheal malposition and entrapment in a bronchial suture]. Ann Fr Anesth Reanim (1998) 1.59

Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache (1983) 1.58

Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache. Neurology (2010) 1.58

Geographical distribution of diabetes among the native population of Canada: a national survey. Soc Sci Med (1990) 1.57

Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology (2000) 1.56

Orofacial migraine. Cephalalgia (2007) 1.55

Long-term efficacy of sodium oxybate in 4 patients with chronic cluster headache. Neurology (2011) 1.53

Spontaneous low cerebrospinal pressure: a mini review. Neurol Sci (2004) 1.53

Ergotamine in the acute treatment of migraine: a review and European consensus. Brain (2000) 1.52

Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache. N Engl J Med (2001) 1.49

The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci (2005) 1.48

Influence of ancestral gender on transmission of familial amyotrophic lateral sclerosis. Lancet (1994) 1.46

Botulinum toxin in headache treatment: the end of the road? Cephalalgia (2006) 1.46

Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study. Dig Liver Dis (2008) 1.46

Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review. Cephalalgia (2004) 1.45

The clinical characteristics of headache in patients with pituitary tumours. Brain (2005) 1.44

Cortical spreading depression-associated cerebral blood flow changes induced by mechanical stimulation are modulated by AMPA and GABA receptors. Cephalalgia (2010) 1.44

EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol (2006) 1.43

Benefits and barriers associated with participation in food programs in three low-income Ontario communities. Can J Diet Pract Res (2001) 1.43

Cost of illness studies in health care: a comparison of two cases. Health Policy (1993) 1.43

Efficacy of fixed combinations of acetylsalicyclic acid, acetaminophen and caffeine in the treatment of idiopathic headache: a review. Eur J Neurol (2010) 1.42

Lung ultrasound-guided management of acute breathlessness during pregnancy. Anaesthesia (2012) 1.40

[Selective digestive decontamination: the light as changed from red to green]. Ann Fr Anesth Reanim (2005) 1.39

[Management of glycemia: an audit in 66 ICUs]. Ann Fr Anesth Reanim (2013) 1.39

Structural fluctuations of myoglobin from normal-modes, Mössbauer, Raman, and absorption spectroscopy. Biophys J (1996) 1.39

Vasodilator agents and supracollicular transection fail to inhibit cortical spreading depression in the cat. Cephalalgia (1999) 1.38

[Airway management for anaesthesia performed at the end of labour: survey of practices]. Ann Fr Anesth Reanim (2008) 1.38

[A vicious circle when headache medication is the cause of chronic headache. A well-planned ambulatory detoxication can result in dramatic improvement]. Lakartidningen (2001) 1.38

Treatment of immigrants and residents suffering from neuro-AIDS on a neurological intensive care unit: epidemiology and predictors of outcome. Acta Neurol Belg (2013) 1.38

High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit Care Med (2000) 1.38

The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version. Cephalalgia (2001) 1.38

Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey. Neurology (2003) 1.37

Physical activity and headache: results from the Nord-Trøndelag Health Study (HUNT). Cephalalgia (2008) 1.31

Headache associated with sexual activity: demography, clinical features, and comorbidity. Neurology (2003) 1.30

Motor neuron disease in the province of Turin, Italy, 1966-1980. Survival analysis in an unselected population. J Neurol Sci (1985) 1.29

Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia (2009) 1.29

Low temperature optical absorption spectroscopy: an approach to the study of stereodynamic properties of hemeproteins. Eur Biophys J (1995) 1.27

Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol (1999) 1.26

EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol (2008) 1.25

The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience (2001) 1.24

Defective T cell fas function in patients with multiple sclerosis. Neurology (2000) 1.24

Headache prevalence among adolescents--the German DMKG headache study. Cephalalgia (2007) 1.24

Diagnostic delays and mis-management in cluster headache. Acta Neurol Scand (2004) 1.22

Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res (1993) 1.21

Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain (2003) 1.21

Use of complementary and alternative medicine in patients suffering from primary headache disorders. Cephalalgia (2009) 1.21

Frequency of seizures and epilepsy in neurological HIV-infected patients. Seizure (2007) 1.21

The incidence and prevalence of cluster headache: a meta-analysis of population-based studies. Cephalalgia (2008) 1.20

Optical absorption spectra of deoxy- and oxyhemoglobin in the temperature range 300-20 K. Relation with protein dynamics. Biophys Chem (1986) 1.19

Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). J Headache Pain (2012) 1.19

Anaerovorax odorimutans gen. nov., sp. nov., a putrescine-fermenting, strictly anaerobic bacterium. Int J Syst Evol Microbiol (2000) 1.16

A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia (2001) 1.16

Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data. Cephalalgia (1998) 1.16

Animal models of migraine: looking at the component parts of a complex disorder. Eur J Neurosci (2006) 1.16

Decreased carotid arterial resistance in cats in response to trigeminal stimulation. J Neurosurg (1984) 1.15

One-year prevalence of migraine in Sweden: a population-based study in adults. Cephalalgia (2001) 1.14

Protein dynamics. Comparative investigation on heme-proteins with different physiological roles. Biophys J (1991) 1.13